CoChat

Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasms

Open access
Bhagwat, Neha, Koppikar, Priya, Keller, Matthew, Marubayashi, Sachie, Shank, Kaitlyn, Rampal, Raajit, Qi, Jun, Kleppe, Maria, Patel, Hardik J., Shah, Smit K., Taldone, Tony, Bradner, James E., Chiosis, Gabriela, Levine, Ross L. · 2014 · Blood
Cited by 110

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Key Points: Genetic deletion of JAK2 in vivo shows that MPN cells remain fully dependent on JAK2 signaling for survival. Dual JAK2 targeting with JAK and HSP90 inhibitors offers increased efficacy in murine models and primary samples.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2014-01-547760

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 110

Metadata

Authors
Bhagwat, N., Koppikar, P., Keller, M., Marubayashi, S., Shank, K., Rampal, R., Qi, J., Kleppe, M., Patel, H. J., Shah, S. K., Taldone, T., Bradner, J. E., Chiosis, G., & Levine, R. L.
Venue
Blood
Published
2014-03-27
Volume
123
Issue
13
Pages
2075-2083
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1976156018
Cited by
110
References
4
FWCI
7.65
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasms. https://app.cochat.ai/papers/10.1182/blood-2014-01-547760
The paper
Bhagwat, N., Koppikar, P., Keller, M., Marubayashi, S., Shank, K., Rampal, R., Qi, J., Kleppe, M., Patel, H. J., Shah, S. K., Taldone, T., Bradner, J. E., Chiosis, G., & Levine, R. L. (2014). Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasms. Blood. https://doi.org/10.1182/blood-2014-01-547760

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.